Cargando…

Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections

Omicron variant is circulating in the presence of a globally acquired immunity unlike the ancestral SARS-CoV-2 isolate. Herein, we investigated the normalized viral load dynamics and viral culture status in 44 fully vaccinated healthcare workers (HCWs) infected with the Omicron BA.1 variant. Viral l...

Descripción completa

Detalles Bibliográficos
Autores principales: Saade, Carla, Brengel-Pesce, Karen, Gaymard, Alexandre, Trabaud, Mary-Anne, Destras, Gregory, Oriol, Guy, Cheynet, Valérie, Debombourg, Marion, Mokdad, Bouchra, Billaud, Geneviève, Oblette, Antoine, Créhalet, Hervé, Giannoli, Jean-Marc, Garrigou, Christine, Generenaz, Laurence, Compagnon, Christelle, Boibieux, André, Lina, Bruno, Morfin, Florence, Pozzetto, Bruno, Josset, Laurence, Touillet-Assant, Sophie, Bal, Antonin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621261/
https://www.ncbi.nlm.nih.gov/pubmed/36098494
http://dx.doi.org/10.1080/22221751.2022.2122578
_version_ 1784821501345660928
author Saade, Carla
Brengel-Pesce, Karen
Gaymard, Alexandre
Trabaud, Mary-Anne
Destras, Gregory
Oriol, Guy
Cheynet, Valérie
Debombourg, Marion
Mokdad, Bouchra
Billaud, Geneviève
Oblette, Antoine
Créhalet, Hervé
Giannoli, Jean-Marc
Garrigou, Christine
Generenaz, Laurence
Compagnon, Christelle
Boibieux, André
Lina, Bruno
Morfin, Florence
Pozzetto, Bruno
Josset, Laurence
Touillet-Assant, Sophie
Bal, Antonin
author_facet Saade, Carla
Brengel-Pesce, Karen
Gaymard, Alexandre
Trabaud, Mary-Anne
Destras, Gregory
Oriol, Guy
Cheynet, Valérie
Debombourg, Marion
Mokdad, Bouchra
Billaud, Geneviève
Oblette, Antoine
Créhalet, Hervé
Giannoli, Jean-Marc
Garrigou, Christine
Generenaz, Laurence
Compagnon, Christelle
Boibieux, André
Lina, Bruno
Morfin, Florence
Pozzetto, Bruno
Josset, Laurence
Touillet-Assant, Sophie
Bal, Antonin
author_sort Saade, Carla
collection PubMed
description Omicron variant is circulating in the presence of a globally acquired immunity unlike the ancestral SARS-CoV-2 isolate. Herein, we investigated the normalized viral load dynamics and viral culture status in 44 fully vaccinated healthcare workers (HCWs) infected with the Omicron BA.1 variant. Viral load dynamics of 38 unvaccinated HCWs infected with the 20A variant during the first pandemic wave was also studied. We then explored the impact of Omicron infection on pre-existing immunity assessing anti-RBD IgG levels, neutralizing antibody titres against 19A, Delta and Omicron isolates, as well as IFN-γ release following cell stimulation with SARS-CoV-2 peptides. We reported that two weeks after diagnosis a greater proportion of HCWs infected with 20A (78.9%, 15/19) than with Omicron BA.1 (44.7%, 17/38; p = 0.02) were still positive by RT-qPCR. We found that Omicron breakthrough infections led to an overall enhancement of vaccine-induced humoral and cellular immunity as soon as a median [interquartile range] of 8 [7–9] days post symptom onset. Among samples with similar high viral loads, non-culturable samples exhibited higher neutralizing antibody titres and anti-RBD IgG levels than culturable samples. Additionally, Omicron infection led to an enhancement of antibodies neutralization capacity against other SARS-CoV-2 isolates. Taken together, the results suggest that Omicron BA.1 vaccine breakthrough infection is associated with a faster viral clearance than that of the ancestral SARS-CoV-2, in addition this new variant leads to a rapid enhancement of the humoral response against multiple SARS-CoV-2 variants, and of the cellular response.
format Online
Article
Text
id pubmed-9621261
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-96212612022-11-01 Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections Saade, Carla Brengel-Pesce, Karen Gaymard, Alexandre Trabaud, Mary-Anne Destras, Gregory Oriol, Guy Cheynet, Valérie Debombourg, Marion Mokdad, Bouchra Billaud, Geneviève Oblette, Antoine Créhalet, Hervé Giannoli, Jean-Marc Garrigou, Christine Generenaz, Laurence Compagnon, Christelle Boibieux, André Lina, Bruno Morfin, Florence Pozzetto, Bruno Josset, Laurence Touillet-Assant, Sophie Bal, Antonin Emerg Microbes Infect Coronaviruses Omicron variant is circulating in the presence of a globally acquired immunity unlike the ancestral SARS-CoV-2 isolate. Herein, we investigated the normalized viral load dynamics and viral culture status in 44 fully vaccinated healthcare workers (HCWs) infected with the Omicron BA.1 variant. Viral load dynamics of 38 unvaccinated HCWs infected with the 20A variant during the first pandemic wave was also studied. We then explored the impact of Omicron infection on pre-existing immunity assessing anti-RBD IgG levels, neutralizing antibody titres against 19A, Delta and Omicron isolates, as well as IFN-γ release following cell stimulation with SARS-CoV-2 peptides. We reported that two weeks after diagnosis a greater proportion of HCWs infected with 20A (78.9%, 15/19) than with Omicron BA.1 (44.7%, 17/38; p = 0.02) were still positive by RT-qPCR. We found that Omicron breakthrough infections led to an overall enhancement of vaccine-induced humoral and cellular immunity as soon as a median [interquartile range] of 8 [7–9] days post symptom onset. Among samples with similar high viral loads, non-culturable samples exhibited higher neutralizing antibody titres and anti-RBD IgG levels than culturable samples. Additionally, Omicron infection led to an enhancement of antibodies neutralization capacity against other SARS-CoV-2 isolates. Taken together, the results suggest that Omicron BA.1 vaccine breakthrough infection is associated with a faster viral clearance than that of the ancestral SARS-CoV-2, in addition this new variant leads to a rapid enhancement of the humoral response against multiple SARS-CoV-2 variants, and of the cellular response. Taylor & Francis 2022-10-26 /pmc/articles/PMC9621261/ /pubmed/36098494 http://dx.doi.org/10.1080/22221751.2022.2122578 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Coronaviruses
Saade, Carla
Brengel-Pesce, Karen
Gaymard, Alexandre
Trabaud, Mary-Anne
Destras, Gregory
Oriol, Guy
Cheynet, Valérie
Debombourg, Marion
Mokdad, Bouchra
Billaud, Geneviève
Oblette, Antoine
Créhalet, Hervé
Giannoli, Jean-Marc
Garrigou, Christine
Generenaz, Laurence
Compagnon, Christelle
Boibieux, André
Lina, Bruno
Morfin, Florence
Pozzetto, Bruno
Josset, Laurence
Touillet-Assant, Sophie
Bal, Antonin
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
title Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
title_full Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
title_fullStr Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
title_full_unstemmed Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
title_short Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
title_sort dynamics of viral shedding during ancestral or omicron ba.1 sars-cov-2 infection and enhancement of pre-existing immunity during breakthrough infections
topic Coronaviruses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621261/
https://www.ncbi.nlm.nih.gov/pubmed/36098494
http://dx.doi.org/10.1080/22221751.2022.2122578
work_keys_str_mv AT saadecarla dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT brengelpescekaren dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT gaymardalexandre dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT trabaudmaryanne dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT destrasgregory dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT oriolguy dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT cheynetvalerie dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT debombourgmarion dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT mokdadbouchra dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT billaudgenevieve dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT obletteantoine dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT crehaletherve dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT giannolijeanmarc dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT garrigouchristine dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT generenazlaurence dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT compagnonchristelle dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT boibieuxandre dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT linabruno dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT morfinflorence dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT pozzettobruno dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT jossetlaurence dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT touilletassantsophie dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections
AT balantonin dynamicsofviralsheddingduringancestraloromicronba1sarscov2infectionandenhancementofpreexistingimmunityduringbreakthroughinfections